Prevalence and predictive features of metabolic dysfunction-associated steatotic liver disease in type 1 diabetes.
Fuhri Snethlage CM, Meijnikman AS, Mak AL, Rampanelli E, Voermans B, Callender CAK, de Groen P, Roep BO, van Raalte DH, Knop FK, Holleboom AG, Nieuwdorp M, Hanssen NMJ.
Fuhri Snethlage CM, et al. Among authors: callender cak.
Eur J Endocrinol. 2024 May 2;190(5):391-400. doi: 10.1093/ejendo/lvae043.
Eur J Endocrinol. 2024.
PMID: 38679966